BIOMARIN PHARMACEUTICAL INC reports

Company location: Novato, CA
Fiscal year end: 31 December

BIOMARIN PHARMACEUTICAL INC has filed 2,729 SEC EDGAR filings since 04 May 1999

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 351-375 of 1,000 matching filings.

Per page

25

Current page

15

4

FORM 4

Filing date: 15 Dec 2022
Reporting date: 13 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 15 Dec 2022
Reporting date: 13 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Dec 2022
Reporting date: 02 Dec 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 06 Dec 2022
Reporting date: 02 Nov 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 28 Nov 2022
Reporting date: 23 Nov 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 04 Nov 2022
Reporting date: 02 Nov 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 02 Nov 2022
Reporting date: 31 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Nov 2022
Reporting date: 31 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-26727

10-Q

Filing date: 28 Oct 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-26727

8-K

Filing date: 26 Oct 2022
Reporting date: 26 Oct 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 18 Oct 2022
Reporting date: 14 Oct 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 000-26727

8-K

Filing date: 07 Oct 2022
Reporting date: 06 Oct 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-26727

8-K

Filing date: 12 Sep 2022
Reporting date: 12 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 16 Aug 2022
Reporting date: 12 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 12 Aug 2022
Reporting date: 11 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Aug 2022
Reporting date: 09 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 10 Aug 2022
Reporting date: 08 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 09 Aug 2022
Reporting date: 05 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 000-26727

10-Q

Filing date: 04 Aug 2022
Reporting date: 30 Jun 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 000-26727

8-K

Filing date: 03 Aug 2022
Reporting date: 03 Aug 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4

Filing date: 12 Jul 2022
Reporting date: 08 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 11 Jul 2022
Reporting date: 08 Jul 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 01 Jul 2022
Reporting date: 29 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 07 Jun 2022
Reporting date: 03 Jun 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

FORM 4

Filing date: 31 May 2022
Reporting date: 29 Apr 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .